US Patent Issued to Dana-Farber Cancer Institute, The United States of America, as represented by the Secretary, Department of Health and Human Services on Oct. 6 for "Antiviral structurally-stabilized Ebolavirus peptides and uses thereof" (Maryland, Massachusetts, New Hampshire, Texas Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,208, issued on Oct. 6, was assigned to Dana-Farber Cancer Institute Inc. (Boston) and The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Antiviral structurally-stabilized Ebolavirus peptides and uses thereof" was invented by Federico Bernal (Gaithersburg, Md.), Amanda L. Whiting (Dallas), Loren D. Walensky (Newton, Mass.) and Gregory H. Bird (Pelham, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure features structurally-stabilized Ebola virus antiviral peptides. Also disclosed are methods of using such structurally-stabilized peptides in the treatment or preventi...